Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

NCT04286789 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Low dose ORTD-1
DRUG: Low dose vehicle control
DRUG: High dose ORTD-1
DRUG: High dose vehicle control

Sponsor

Oryn Therapeutics, LLC